The Pennant Group, Inc. $PNTG Shares Newly Purchased by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. purchased a new position in shares of The Pennant Group, Inc. (NASDAQ:PNTG) during the third quarter, Holdings Channel reports. The firm purchased 32,795 shares of the company’s stock, valued at approximately $1,279,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sigma Planning Corp acquired a new stake in shares of The Pennant Group in the 3rd quarter valued at approximately $1,573,000. Sterling Capital Management LLC grew its position in The Pennant Group by 846.7% during the 3rd quarter. Sterling Capital Management LLC now owns 1,136 shares of the company’s stock worth $44,000 after acquiring an additional 1,016 shares during the last quarter. Kings Path Partners LLC bought a new stake in The Pennant Group during the 3rd quarter worth $684,000. Pinnacle Associates Ltd. increased its holdings in The Pennant Group by 3.5% in the 3rd quarter. Pinnacle Associates Ltd. now owns 38,594 shares of the company’s stock worth $1,505,000 after purchasing an additional 1,313 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in The Pennant Group by 45.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 3,413 shares of the company’s stock worth $133,000 after purchasing an additional 1,065 shares in the last quarter. 85.88% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Truist Financial lifted their price target on The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings raised The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Wells Fargo & Company raised their target price on The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. Finally, Royal Bank Of Canada upped their price objective on shares of The Pennant Group from $42.00 to $44.00 and gave the company an “outperform” rating in a research note on Thursday, August 20th. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, The Pennant Group currently has an average rating of “Moderate Buy” and a consensus target price of $46.00.

The Pennant Group Stock Performance

Shares of The Pennant Group stock opened at $41.66 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.20 and a quick ratio of 1.20. The Pennant Group, Inc. has a one year low of $22.25 and a one year high of $43.41. The business has a 50-day simple moving average of $39.96 and a 200 day simple moving average of $35.41. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of 46.29, a PEG ratio of 2.72 and a beta of 1.33.

The Pennant Group (NASDAQ:PNTG) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.03. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The business had revenue of $297.98 million during the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, research analysts anticipate that The Pennant Group, Inc. will post 1.18 earnings per share for the current fiscal year.

The Pennant Group Profile

The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.

Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.